Insider filing · TEVA
Matthew Shields
EVP, Global Operations
profile →
Teva Pharmaceutical Industries Limited
TEVA · Healthcare · 60 filings in 24 months
ticker →
Matthew Shields sold $532K of Teva Pharmaceutical Industries Limited (TEVA)
Executed Jun 3, disclosed Jun 4, 1 day later.
Value, as filed
$532K
16,195 sh × $32.87
Executed
Jun 3
the trade date, as filed
Disclosed
Jun 4
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMatthew Shields (EVP, Global Operations) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $548K of TEVA (17,295 sh × $31.67, as filed), executed Mar 5.
The name
TEVAHealthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Matthew Shields in TEVA
TEVASALE
Teva Pharmaceutical Industries Limited
$322K9,989 sh × $32.19
Exec Jun 18
Filed Jun 22 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $548K
17,295 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $106K
6,206 sh × $17.02
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET